Determining Patent
Term
Utility Patent protection in the
US generally stays in force for twenty years.
At the same time, there are other factors that need to be considered in calculating
patent term, including:
- Priority Date or Earliest Effective Filing Date
- Patent Term Adjustment (PTA)
- Terminal Disclaimer (TD)
- Maintenance Fees
- Patent Term Extension (PTE)
MaxVal’s Patent Term Estimation Service/Tool:
MaxVal offers comprehensive
calculations of patent term estimation, considering all the aforementioned
conditions. MaxVal
also provides a free online tool, Patent
Term Estimator that makes it easy to calculate patent term and expiry* date of
US utility patents.
The table below (sourced from Patent Maker)
illustrates some of the pharma and consumer electronics patents that expired*
in April 2014 along with the
respective products covered.
U.S. Patent
Number
Title
|
Owner/Assignee
|
Products Covered
|
Category
|
Low toxicity drug-lipid systems
|
Abelcet
|
Pharma
|
|
Composition and galenic formulation suitable for
combatting affections of the lower abdomen
|
Alinia
|
Pharma
|
|
Dosage forms of risedronate
|
Atelvia
|
Pharma
|
|
Angiotensin II antagonist 1-biphenylmethylimidazole
compounds and their therapeutic use
|
Azor
|
Pharma
|
|
Benicar
|
|||
Benicar HCT
|
|||
External anti-inflammatory and analgesic plaster
preparation
|
Teikoku
Seiyaku Co., Ltd.
Altergon
S.A
|
Flector
|
Pharma
|
Treatment of partial growth hormone insensitivity
syndrome
|
Increlex
|
Pharma
|
|
3-(Het) arylcarboxylic acid derivatives, their
preparation and intermediates for their preparation
|
Letairis
|
Pharma
|
|
Ketoconazole shampoo containing butylated hydroxytoluene
or butylated hydroxyanisole
|
Nizoral A-D
|
Pharma
|
|
Insulin analogues
|
Novolog
|
Pharma
|
|
Flexpen
|
|||
Innolet
|
|||
Mix 50/50
|
|||
Mix 70/50
|
|||
Mix 70/30
Flexpen
|
|||
Mix 70/30
Penfill
|
|||
Penfill
|
|||
Method for preventing a second heart attack employing an
HMG CoA reductase inhibitor
|
Pravachol
|
Pharma
|
|
Pravigard
Pac (Copackaged)
|
|||
Container for anaesthetic agent
|
Suprane
|
Pharma
|
|
Rapamycin hydroxyesters
|
Torisel
|
Pharma
|
|
Composition and method for treatment of CMV retinites
|
Vitravene Preservative
Free
|
Pharma
|
|
Radiopaque stent
|
Advanced
Cardiovascular Systems
|
Absolute Pro Vascular
Self-Expanding Stent System
|
Health Resources
|
Recombinant expression vectors and purification methods
for Thermus thermophilus DNA polymerase
|
GeneSnare Differential
Expression Kit
|
Health Resources
|
|
Coiled reinforced retractable sleeve for stent delivery
catheter
Catheter with perfusion system
Catheters having separable reusable components
|
Guidant Multi-Link Vision
Coronary Stent System
|
Health Resources
|
|
BMP-2 products
|
Infuse Bone Graft
|
Health Resources
|
|
Method and apparatus for creating motion picture
transitions according to non-linear light response
|
Avid DS
|
Electronics
|
|
Media Composer
|
|||
Media Composer Mojo/
Nitris DX
|
|||
NewsCutter
|
|||
NewsCutter Mojo/ Nitris DX
|
|||
Symphony
|
|||
Digitizer for a bar code reader utilizing a first
derivative signal and an analog ground comparison signal
|
Itronix fex21
|
Electronics
|
|
Method and apparatus for reducing off-channel
interference produced by a linear transmitter
Portable radio battery latch
|
Motorola i700plus
|
Electronics
|
|
Method for controlling configuration of laser induced
breakdown and ablation
|
iFS Laser System
|
Vision
|
Patent Marker is a
database of products and patents, in which the patents that apply to each
product are identified. Any registered user is free to add a product for
marking. Patent Marker is an online tool that makes it easy for companies/patentees
to mark their products and serve notice to the public of their ownership of inventions.
The database
includes powerful search functionality that can be used to identify products
and their related-patents, patent expiration date, number of litigations the
patent is involved, etc. The database interfaces with MaxVal’s Litigation Databank and Assignment
Database to retrieve litigation and current assignee information,
respectively.
No comments:
Post a Comment